BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27452220)

  • 1. MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.
    Lohcharoenkal W; Harada M; Lovén J; Meisgen F; Landén NX; Zhang L; Lapins J; Mahapatra KD; Shi H; Nissinen L; Kähäri VM; Ståhle M; Sonkoly E; Grandér D; Arsenian-Henriksson M; Pivarcsi A
    J Invest Dermatol; 2016 Dec; 136(12):2485-2494. PubMed ID: 27452220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.
    Olasz EB; Seline LN; Schock AM; Duncan NE; Lopez A; Lazar J; Flister MJ; Lu Y; Liu P; Sokumbi O; Harwood CA; Proby CM; Neuburg M; Lazarova Z
    PLoS One; 2015; 10(5):e0125412. PubMed ID: 25938461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
    Ma X; Wu D; Zhang X; Shao X; Hu G
    Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
    Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
    J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1.
    Lohcharoenkal W; Li C; Das Mahapatra K; Lapins J; Homey B; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2021 Aug; 141(8):1922-1931. PubMed ID: 33766507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
    Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
    Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
    Bai X; Zhou Y; Chen P; Yang M; Xu J
    J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
    J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
    Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
    Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
    Wang J; Li C; Xu L; Yang C; Zhang X
    Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.
    Chen B; Pan W; Lin X; Hu Z; Jin Y; Chen H; Ma G; Qiu Y; Chang L; Hua C; Zou Y; Gao Y; Ying H; Lv D
    Tumour Biol; 2016 Feb; 37(2):2765-71. PubMed ID: 26408183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.
    Wang A; Landén NX; Meisgen F; Lohcharoenkal W; Ståhle M; Sonkoly E; Pivarcsi A
    PLoS One; 2014; 9(7):e103206. PubMed ID: 25068518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR-342-3p expression.
    Zhang Z; Jia M; Wen C; He A; Ma Z
    J Gene Med; 2020 Dec; 22(12):e3242. PubMed ID: 32558970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas.
    Stojadinovic O; Ramirez H; Pastar I; Gordon KA; Stone R; Choudhary S; Badiavas E; Nouri K; Tomic-Canic M
    Arch Dermatol Res; 2017 Mar; 309(2):133-139. PubMed ID: 28013372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
    Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
    Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
    Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.